Circulating adiponectin concentrations are reduced in obese individuals, and this reduction
has been proposed to have a crucial role in the pathogenesis of atherosclerosis and …

Background. Newer antidiabetic drugs, ie, dipeptidyl peptidase‐4 (DPP‐4) inhibitors,
sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors, and glucagon‐like peptide‐1 receptor …

Vascular calcification (VC) has been well-established as an independent and strong
predictor of cardiovascular diseases (CVD) as well as major cardiac adverse events …

Background Safety of sulfonylurea drugs in the treatment of Type 2 Diabetes is still under
debate. The aim of this study was to compare the all-cause mortality and cardiovascular …

Endothelium, acting as a barrier, protects tissues against factors that provoke insulin
resistance and type 2 diabetes and itself responds to the insult of insulin resistance inducers …

Dipeptidyl peptidase 4 (DPP4) is a serine protease known to cleave incretin hormones,
which stimulate insulin secretion after food intake, a fact that supported the development of …

Background To investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal
outcomes in patients with type 2 diabetes. Methods MEDLINE, Embase, and the Cochrane …

A central problem in most data-driven personalized medicine scenarios is the estimation of
heterogeneous treatment effects to stratify individuals into subpopulations that differ in their …

Background The changes of endothelial function in type 2 diabetes mellitus (T2DM) patients
are closely associated with the development of cardiovascular disease (CVD). However, it is …

Flow-mediated dilation (FMD) is a noninvasive method to evaluate vascular endothelial
function, which manifests the vascular inflammatory response, cell proliferation, and …